Revolutionizing CAR T-cell therapy with decentralized science. Targeting Multiple Myeloma and beyond! #DeSci #Biotecht.me/GoCART_De_Sci BerlinJoined March 2025
Great to see more validation for patient-centric biotech models. The launch of @VibeBio to serve rare disease communities shows the power of this growing movement.
This is what DeSci is all about: empowering patients and communities.
businesswire.com/news/home/2022…
Patient-reported data from @ASCO shows that toxicity is a top concern for multiple myeloma patients receiving CAR T.
This is why our AND-gate platform is focused on safety. Listening to the patient experience is key to building better therapies.
asco.org/abstracts-pres…
Your body has its own cancer killers: T-cells and NK cells. They have different methods for eliminating threats. Here's a 60-second science lesson
#Immunology#Scienceyoutube.com/shorts/5A7rBe2…
How does CAR T-cell therapy work? The @AmericanCancer provides a great primer on the fundamentals.
We're building the next generation of this technology with our AND-gate platform to make it safer and more precise.
#MultipleMyelomacancer.org/cancer/types/m…
New real-world data in @BCJ_Nature highlights the challenge of relapse in multiple myeloma. Creating more durable therapies is a critical unmet need.
This is why we're building next-gen platforms like our AND-gate to improve long-term outcomes.
nature.com/articles/s4140…
Did you know? 1 in 3 older Americans dies w/ Alzheimer’s or dementia - more than breast & prostate cancer combined.
DeSci is about funding better science, faster.
$FIDEL token going live on Molecule next week w/ @Cerebrum_DAO@vita_dao@beakerdao and more...
Why does pharma struggle with new tools?
At @DeSciBerlin, Estefania 'Nia' Escobar-Kölle from @Future4care explained why human habits, lack of transparency, and patient dynamics slow innovation in R&D.
DeSci is accelerating and so is D1ckDAO!
We've completed two core missions. The path to a new era of men's health is now open.
💊 Libio pilot study is LIVE
🤖 We took a giant leap into the Agentic future with "D1ck AI"
A full update on our latest progress and what's next. 🧵
Why does great science die in the lab? The 'valley of death' between academia and industry is real. DeSci helps bridge that gap. As Henry asks, "If you can't deliver it to patients, is it a solution?"
#DeSci#Biotech
🔗 youtube.com/shorts/7k5fkkI…
Exciting immunotherapy innovation in this @Nature paper. It details an oncolytic bacteria platform sharing our goal: making therapies safer & more adaptable. Could have powerful synergies w/ CAR T in the future.
🔗 nature.com/articles/s4155…
Great review in @Nature on the challenge of the tumor microenvironment (TME) for CAR-T therapy. The TME can suppress even advanced treatments, making TME-resistant strategies critical.
This is why we build. Next-gen logic is needed. #CellTherapy#Oncologynature.com/articles/s4139…
We're excited to announce our new collaboration with @immunochem!
Their deep expertise in developing high-quality monoclonal antibodies will be a key asset as we build out our modular binder portfolio for new cancer targets.
Happy 4th! 🇺🇸🎆
#BioTech#Collaboration#Antibodies
📢 Partnership News: GoCART is excited to announce a new strategic collaboration with Oncera! bit.ly/4kmdd2e
Together, we will work on expanding our portfolio of binders for novel cancer targets, accelerating our mission to build safer, more precise cell therapies.
Game-changing Science alert!
Dr. Henry Erdlei from @GoCART_DeSci is turning immune cells into cancer-fighting machines through CAR T-cell therapy!
Watch now:
youtu.be/RICO7fxuhwQ
What does "in vitro proof-of-concept" mean?
It's our next major milestone: proving our AND-gate system works in a controlled lab environment. This is the foundational data that bridges our computer models with real-world biology. #GoCART#Science#Roadmap
The challenge of relapse in Multiple Myeloma is a key focus for next-gen therapies. Understanding the mechanisms of resistance is critical for developing more durable treatments.
This paper offers a deep dive into the topic: frontiersin.org/journals/immun…#GoCART#CancerResearch
📢 Partnership News: GoCART is thrilled to announce a new collaboration with Cadiz University in Spain!
This partnership provides us with state-of-the-art lab space and resources to accelerate our R&D and move our AND-gate platform closer to the clinic. #GoCART#BioTech#Science
3K Followers 1K Following| hunting airdrop is my top priority|
|Ambassador for projects |Space Host |
👉join my WhatsApp for alphas👉👉https://t.co/SvniWv7zJH
30K Followers 2K FollowingDeSci biopharma IP tokenization protocol.
Fund & shape early-stage research ideas on https://t.co/wLCqaJVkVq & https://t.co/7oSlMRrzV8
19 Followers 249 FollowingBiopharma / clinical dev. Pushing for change and Web3. Advocating shift from Trad-Fi/Sci/Pharm to DeFi/Sci/Pharm. Rewrite the rule book.
7K Followers 3K FollowingHunting Coins in @underground
Pycnogonidae in @0xTheBigBlue
Researcher in @WizardsCap
Sleepor in @NoMoreLiquidity
Blue Life Science Engineer exploring Web3
2K Followers 269 FollowingSpectruth DAO uses AI 🤖, epigenetics 🧬 Ibogaine💉& wearables ⌚ to revolutionize PTSD care and therapy 🔗backed by @BioProtocol
🌐 https://t.co/qQJhDogZdt
297 Followers 931 FollowingSpace Accelerationist | I believe in the Singularity: democratizing science, decentralizing AI, and building distributed space systems. #DePIn #DeSci #DeSpace
287 Followers 529 FollowingNicaraguan. Scientist in the making. Bacteria lover driven by the amazing world of biofilms. #Fulbright & #Schlumberger scholar
2K Followers 408 FollowingNonprofit raising funds for pediatric cancer #immunotherapy research. Emily is a 3x leukemia survivor & 1st child to receive #CARTcell therapy. #ActivateTheCure
180K Followers 4K FollowingWriting at https://t.co/m6EtO60SiY and host of the Core Memory podcast. 2X NYT best-seller. Filmmaker @HBO (Wild, Wild Space) + @Netflix (Don't Die).
499K Followers 1K FollowingProfessor @Harvard researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own 🙏✌️
318K Followers 2K FollowingPublishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
2.6M Followers 3K FollowingResearch, News, and Commentary from Nature, the international science journal
For daily science news, get Nature Briefing: https://t.co/wGmQlQ8a4D
2K Followers 1K FollowingA community dedicated to the production and promotion of longevity media - movies, series, games, and more. Join: https://t.co/5QUZ0cKaxn
4K Followers 2K FollowingBuilding a new city for people who want limitless health in our lifetime: @CityOfViva ⛲️ + co-creator of @Vita_DAO, @JellyfishDAO, @BeakerDAO, Zuzalu, Vitalia
569K Followers 0 FollowingLaunch a coin that is instantly tradeable in one click for free: https://t.co/5I8qHw6eDl Support: https://t.co/AodX1mIezE Download the mobile app 👇🏻
13K Followers 1K FollowingTransformative women’s health R&D funding, education, and access. Building the field of Fertility Acceleration. Join 👉 https://t.co/8hwhrqeu3A
2K Followers 269 FollowingSpectruth DAO uses AI 🤖, epigenetics 🧬 Ibogaine💉& wearables ⌚ to revolutionize PTSD care and therapy 🔗backed by @BioProtocol
🌐 https://t.co/qQJhDogZdt
12K Followers 344 FollowingValleyDAO is a leading DeSci platform funding and accelerating climate-focused biotech research.
👉 Get $GROW on ETH & SOL: https://t.co/QkSSkwtE1j
22K Followers 8K FollowingWe build infrastructure for open and transparent scientific publishing of papers, data, and code. Powered by cutting-edge Web3 & AI technology. #DeSci
4K Followers 393 FollowingYour gut. Your data. Your rules. Backed by science, run by microbes, owned by the crowd. Powered by @BioProtocol Join us: https://t.co/YV0JDHQ4x9
3K Followers 393 FollowingWe are redesigning spine health for the next era of medicine. Our ecosystem includes AI-native spine care. Precision, speed, and scale. $SPINE: spinez..AoXtSjR
58K Followers 257 Followinglaunch a science experiment that is instantly tradable: https://t.co/tvJg05CuqH
the game is don't die
come play
https://t.co/tf8nQq4vyw
9K Followers 2K FollowingA global online platform providing the latest treatment options & medical information on multiple myeloma https://t.co/I985R5jtY7 #mmsm #myeloma
16K Followers 982 Followingtokenizing psychedelic IP on https://t.co/Yjo5AJBSLw | 💜 | incubated by @molecule_dao and @bioprotocol | sponsor of @BeeARDai 🐝 and @pumppsy
45K Followers 6K FollowingVitaDAO is a community owned collective funding early stage longevity research,governed by $VITA-holders 🧬 👉https://t.co/uq15UrsgHO
No recent Favorites. New Favorites will appear here.